By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mirna Therapeutics, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-901-0900 Fax: 512-681-5201


Company News
The End Of The Road: Mirna To Cease Operations After Merger With Synlogic 5/17/2017 6:05:38 AM
Mirna Reports First Quarter 2017 Financial Results 5/10/2017 6:52:44 AM
Mirna Reports Financial Results For The Fourth Quarter And Full Year Ended December 31, 2016 3/15/2017 8:02:13 AM
Mirna Reports Third Quarter 2016 Financial Results And MRX34 Clinical Program Updates 11/11/2016 1:22:46 PM
Mirna Halts Clinical Study of Lead Drug After Patients Get Sick 9/21/2016 7:17:05 AM
Mirna To Participate In Two Healthcare Investor Conferences In September 8/31/2016 10:42:38 AM
Mirna Reports Second Quarter 2016 Financial Results And Program Updates 8/15/2016 11:59:33 AM
Mirna To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference 7/5/2016 8:02:18 AM
Mirna Appoints Perry Nisen, M.D., Ph.D., To Its Board Of Directors 6/30/2016 8:57:11 AM
ASCO2016: Mirna Announces Clinical Data On Its Lead Microrna Therapeutic Presented At ASCO 6/6/2016 2:54:11 PM